- active not recruitingPHASE3
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
This study is testing a new combination treatment for advanced ovarian, fallopian tube, or peritoneal cancer that has returned or not responded to previous platinum-based chemotherapy. It looks at how well adding a drug called relacorilant to nab-paclitaxel works compared to nab-paclitaxel alone.
United States · Argentina · Australia - active not recruitingPHASE1, PHASE2
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
This study is testing a new drug, BT8009, alone or with another drug called pembrolizumab, for people with advanced cancers. It aims to find a safe and effective dose, understand how the body handles it, and see how well it works against different cancer types.
United States · Canada · France